Sandra Vedrick
Contatto Relazioni con gli Investitori presso REVELATION BIOSCIENCES, INC.
Provenienza dei contatti di primo grado di Sandra Vedrick
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 22 | |
| Public Company | Biotechnology | 7 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Sandra Vedrick tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| HERON THERAPEUTICS, INC. | Biotechnology | Chairman President | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Alpha-Beta Technology, Inc.
 Alpha-Beta Technology, Inc. Electronic ComponentsElectronic Technology Alpha-Beta Technology, Inc. engages in the discovery, development and commercialization of novel carbohydrate-based products for the prevention and treatment of infectious disease. It develops a novel class of immune modulation pharmaceutical products composed of complex carbohydrates and is discovering and developing new anti-fungal diagnostics and drugs. In addition, Alpha-Beta has developed a rapid in vitro diagnostic to detect and monitor systemic fungal infections and has an anti-fungal research program to discover direct inhibitors of fungal cell wall synthesis. It is in the development stage and is devoting substantially all of its efforts toward product research and development, raising capital, marketing products under development, clinical trials and manufacturing. The Company was founded on March 2, 1988 and is headquartered in Worcester, MA. | Electronic Components | Corporate Officer/Principal | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Sales & Marketing Sales & Marketing Corporate Officer/Principal | |
| SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Molecular Imaging Corp.
 Molecular Imaging Corp. Medical/Nursing ServicesHealth Services Molecular Imaging Corp. provides molecular imaging services to the healthcare industry. It is a diagnostic imaging procedure used to diagnose, monitor and assess disease severity for many cancers, cardiovascular disease and neurological disorders. The firm's procedures display metabolic and functional characteristics of disease, which typically are the first indications of disease. It also provides a newer combined MI/CT system. The company was founded by Paul J. Crowe on August 21, 1985 and is headquartered in San Diego, CA. | Medical/Nursing Services | Director of Finance/CFO | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
SeraCare Life Sciences, Inc.
 SeraCare Life Sciences, Inc. Medical SpecialtiesHealth Technology SeraCare Life Sciences, Inc. provides in vitro diagnostics and clinical laboratory products. It supplies diagnostic quality controls, biological materials, and reagents to in vitro diagnostics developers, clinical laboratories, and life science researchers. The firm’s products include Next-Gen Sequencing and Digital PCR Tools, Controls and Reference Materials, Validation and Lot Qualification Materials, Plasma and Serum Diluents/Derivatives, Cell Culture Reagents, KPL Antibodies and Conjugates and KPL Immunoassay Reagents and Kits. The company was founded in 1984 and is headquartered in Milford, MA. | Medical Specialties | Director of Finance/CFO Director of Finance/CFO | |
| MERSANA THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| TETRAPHASE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Sales & Marketing Chief Executive Officer Corporate Officer/Principal | |
CalciMedica, Inc. (US)
 CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member | |
Thesan Pharmaceuticals, Inc.
 Thesan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thesan Pharmaceuticals, Inc. provides novel therapeutics for disorders of the skin. The company focuses on the discovery and development of new chemical entities that provide improved treatment options to patients. Thesan Pharmaceuticals was founded in 2011 by Edward P. Monaghan and is headquartered in Carlsbad, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Boston University | College/University | Undergraduate Degree Masters Business Admin | |
| George Washington University | College/University | Corporate Officer/Principal | |
| San Diego State University | College/University | Masters Business Admin Graduate Degree Undergraduate Degree | |
| Eastern University | College/University | Undergraduate Degree | |
| Texas A&M University | College/University | Undergraduate Degree Undergraduate Degree | |
| Keene State College | College/University | Undergraduate Degree | |
The Ohio University
 The Ohio University Other Consumer ServicesConsumer Services Central Hockey League operates a professional minor league hockey teams playing in small to medium-sized markets primarily in central and southwestern US states. The league, which was started in 1992, is managed and operated by WPHL, a subsidiary of Global Entertainment Corporation. | College/University | Undergraduate Degree | |
| Oregon State University | College/University | Undergraduate Degree Graduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| The University of Colorado | College/University | Masters Business Admin | |
Drug Information Association
 Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
DaVita Clinical Research
 DaVita Clinical Research Medical/Nursing ServicesHealth Services Part of DaVita, Inc., DaVita Clinical Research is a research arm of DaVita that specializes in retrospective research to improve clinical outcomes. The American company assists pharmaceutical and medical device companies in designing, recruiting, and completing clinical trials using its renal research site network. The private company's unique approach is based on a provider-based renal research site network. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
| VA Medical Center (District of Columbia) | General Government | Corporate Officer/Principal | |
ExThera Medical Corp.
 ExThera Medical Corp. Medical/Nursing ServicesHealth Services ExThera Medical Corp. develops medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking. The company develops Seraph Microbind Affinity Blood Filter (Seraph), which captures and removes normal and drug-resistant bacteria, viruses, toxins, and pro-inflammatory cytokines from human blood; and offers solution for use in a dialysis, such as extracorporeal circuit for treating existing bloodstream infections. The company was founded in 2007 and is headquartered in Martinez, CA. | Medical/Nursing Services | Director/Board Member | |
| Surgical Sealants, Inc. | Corporate Officer/Principal | ||
| New Jersey Medical School | College/University | Doctorate Degree | |
| Zicklin School of Business | College/University | Graduate Degree | |
Symmetry Advisors
 Symmetry Advisors Investment ManagersFinance Symmetry Advisors provides investment advisory services. The private company is based in San Diego, CA. | Investment Managers | Corporate Officer/Principal | |
| ODONATE, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Corporate Officer/Principal Director of Finance/CFO | |
La Jolla Pharmaceutical II BV
 La Jolla Pharmaceutical II BV Medical/Nursing ServicesHealth Services Part of Innoviva, Inc., La Jolla Pharmaceutical II BV provides healthcare services. The private company is based in Amsterdam, Netherlands. | Medical/Nursing Services | Director/Board Member | |
| INHIBRX, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
UTILITY therapeutics Ltd.
 UTILITY therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Utility Therapeutics Ltd. is a British company that has exclusive US commercial rights to two European-approved antibiotics, mecillinam and an oral prodrug of mecillinam, for the treatment of urinary tract infections (UTI). The private company is based in Altrincham, UK and was founded in 2018 by Rasmus Toft-Kehler, Morten Otto Alexander Sommer, Peter Aksel Villadsen. Mecillinam is being developed as a first-line therapy for complicated UTI in the hospital setting, while the oral prodrug is being developed for uncomplicated UTI. The company has received the FDA's Qualified Infectious Disease Product (QIDP) designation for the treatment of UTI. Utility Therapeutics is committed to developing antibiotics that meet urgent treatment needs for multi-drug resistant infections. | Pharmaceuticals: Generic | Director/Board Member | |
Kartos Therapeutics, Inc.
 Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Pharmaceuticals: Major | Chief Operating Officer | |
La Jolla Pharma LLC
 La Jolla Pharma LLC Pharmaceuticals: MajorHealth Technology Part of Innoviva, Inc., La Jolla Pharma LLC is a pharmaceutical company that manufactures pharmaceutical products. The private company is based in Dover, DE. | Pharmaceuticals: Major | Chief Executive Officer | |
Z3 Capital LLC
 Z3 Capital LLC Real Estate Investment TrustsFinance Z3 Capital LLC provides real estate investment services. | Real Estate Investment Trusts | Corporate Officer/Principal | |
Clarametyx Biosciences, Inc.
 Clarametyx Biosciences, Inc. BiotechnologyHealth Technology Clarametyx Biosciences, Inc. operates as a biotechnology company. It develops a dynamic pipeline of immune-enabling therapies and vaccines for chronic and recurrent bacterial infections. The company was founded by Michael Triplett, Peter G. Kleinhenz, Juliana Woda, and Charles McOsker and is headquartered in Columbus, OH. | Biotechnology | Director/Board Member | |
Revelation Therapeutics LLC
 Revelation Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Revelation Therapeutics LLC provides biotechnology services. The company is headquartered in Menlo Park, CA. | Miscellaneous Commercial Services | Director of Finance/CFO Director/Board Member | |
Revelation Biosciences Sub, Inc.
 Revelation Biosciences Sub, Inc. Medical SpecialtiesHealth Technology Part of Revelation Biosciences, Inc., Revelation Biosciences Sub, Inc. develops medical devices. The private company is based in San Diego, CA. James M. Rolke has been the CEO of the company since 2020. Revelation Biosciences Sub was acquired by Petra Acquisition, Inc. on January 11, 2022 for $87.36 million. | Medical Specialties | Chairman Director/Board Member Chief Executive Officer Director/Board Member | |
| Geltex, Inc. | Corporate Officer/Principal | ||
| Chicago Medical School | College/University | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 46 |
| Israele | 2 |
| Paesi Bassi | 2 |
| Regno Unito | 2 |
Settori
| Health Technology | 24 |
| Consumer Services | 14 |
| Health Services | 5 |
| Commercial Services | 4 |
| Finance | 3 |
Posizioni
| Corporate Officer/Principal | 71 |
| Director/Board Member | 47 |
| Undergraduate Degree | 24 |
| Director of Finance/CFO | 19 |
| Chief Executive Officer | 17 |
Contatti più connessi
| Insiders | |
|---|---|
| George Tidmarsh | 22 |
| Kevin Tang | 18 |
| Jeffrey Jensen | 13 |
| Clara Ezed | 13 |
| David Ramsay | 13 |
| James Rolke | 12 |
| Larry G. Edwards | 12 |
| Dennis Mulroy | 10 |
| Robert H. Rosen | 9 |
| Jess Roper | 9 |
| Chester Zygmont | 8 |
| Lakhmir Chawla | 8 |
| Thomas J. Ouellette | 8 |
| Stewart M. Kroll | 7 |
| Christopher Galloway | 7 |
- Borsa valori
- Insiders
- Sandra Vedrick
- Connessioni Società
